Elmar Bosies
Roche Diagnostics
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Elmar Bosies.
Lipids | 1987
Elmar Bosies; Dieter Herrmann; Uwe Bicker; Rudi Gall; Wulf Pahlke
The synthesis of thioether phospholipids, which represent a new class of antitumor agents, is reported here. In particular, the route of synthesis of 3-hexadecylmercapto-2-methoxymethylpropyl-2′-trimethylammonio-ethyl phosphate (BM 41.440, Ilmofosine), one of the most potent cytostatic/cytotoxic derivatives, is described in detail. Starting with diethylbis-hydroxymethylmalonate, ethyl 2-phenyl-1,3-dioxane-5-carboxylate is formed via diethyl 2-phenyl-1,3-dioxane-5,5-dicarboxylate and 5-ethoxycarbonyl-2-phenyl-1,3-dioxane-5-carboxylic acid. Reduction of ethyl 2-phenyl-1,3-dioxane-5-carboxylate with LiAlH4 affords 5-hydroxymethyl-2-phenyl-1,3-dioxane. Alkylation with dimethyl sulfate gives 5-methoxymethyl-2-phenyl-1,3-dioxane. The ring structure then is opened byN-bromosuccinimide, resulting in the formation of 3-bromo-2-methoxymethylpropyl benzoate. Reaction of 3-bromo-2-methoxymethylpropyl benzoate with the sodium salt of hexadecanethiol leads to 3-hexadecylmercapto-2-methoxy-methylpropanol, which is reacted with a cyclic chlorophosphate to give the corresponding phosphorylated 3-hexadecylmercapto-2-methoxymethylpropanol. Treatment with trimethylamine yields BM 41.440. This compound already has been tested in clinical phase I/II trials in West Germany.
Phosphorus Sulfur and Silicon and The Related Elements | 1999
Angelika Esswein; Frieder Bauss; Roman Muehlbauer; Harald Guenther; Elmar Bosies
Bisphosphonates (BPs) are powerful inhibitors of bone resorption. They exert a strong affinity to bone mineral which allows the rapid and selective targeting to bone in vivo. We synthesized and evaluated two new classes of compounds: phosphono succinic acid (PSA) and phosphono glutaric acid (PGA) derivatives. In order to transfer the antiresorptive properties of bisphosphonates attempts have been made to elucidate the key elements of the putative BP pharmacophore. Whereas the new compounds revealed similar or better bone mineral affinity properties than BPs in vitro, the inhibition of endogenous bone resorption in vivo was less effective, but in contrast to BPs the effects were reversible after discontinuation of treatment, which suggests that these compounds are metabolically degradable.
Archive | 1987
Rudi Gall; Elmar Bosies
Archive | 1978
Kurt Stach; Elmar Bosies; Ruth Heerdt; Hans-Frieder Kühnle; Felix Helmut Schmidt
Archive | 1985
Elmar Bosies; Rudi Gall
Archive | 1987
Rudi Gall; Elmar Bosies
Archive | 1987
Elmar Bosies; Rudi Gall
Archive | 1989
Elmar Bosies; Harald Zilch
Archive | 1987
Rudi Gall; Elmar Bosies
Archive | 1981
Elmar Bosies; Rudi Gall; Gunter Weimann; Uwe Bicker; Wulf Pahlke